LSC - 2017 - KRAS & TP53 mutations cause malignant mesothelioma
Sign Up to like & getrecommendations! Published in 2017 at "European Respiratory Journal"
DOI: 10.1183/1393003.congress-2017.oa293
Abstract: Background: Malignant pleural mesothelioma (MPM) is a highly aggressive tumor linked to loss of tumor suppressorsBAP1, NF2, andTRP53and accompanied by malignant pleural effusion (MPE). Aim: To develop novel mouse models of MPM with MPE. Methods:… read more here.
Keywords: mpm; mesothelioma; median survival; lsc 2017 ... See more keywords